Y-Intercept (HK)’s Sabra Healthcare REIT SBRA Stock Holding History

Y-Intercept (HK)’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98M	Buy	+152,638	New	+$3.03M	0.06%	480
2025 Q4	–	Sell	-321,988	Closed	-$6M	–	1941
2025 Q3	$6M	Buy	+321,988	New	+$6.01M	0.14%	158
2025 Q2	–	Sell	-49,710	Closed	-$868K	–	1966
2025 Q1	$868K	Buy	+49,710	New	+$838K	0.06%	463
2024 Q2	–	Sell	-67,562	Closed	-$998K	–	1856
2024 Q1	$998K	Buy	67,562 +37,867	+128%	+$524K	0.08%	392
2023 Q4	$424K	Buy	+29,695	New	+$422K	0.04%	673
2023 Q3	–	Sell	-22,095	Closed	-$260K	–	1525
2023 Q2	$260K	Buy	+22,095	New	+$252K	0.03%	831
2022 Q2	–	Sell	-21,443	Closed	-$319K	–	1153
2022 Q1	$319K	Buy	21,443 +2,704	+14%	+$37K	0.07%	426
2021 Q4	$254K	Sell	18,739 -15,308	-45%	-$217K	0.06%	444
2021 Q3	$501K	Buy	+34,047	New	+$575K	0.09%	332

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Y-Intercept (HK)'s SBRA Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Sabra Healthcare REIT (SBRA) in Q2 2026: 152,638 shares worth $2.98M. The stake represents 0.06% of the portfolio and ranks #480 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in SBRA as recently as Q3 2025.

Y-Intercept (HK) first reported a position in SBRA in Q3 2021 and has held it in 9 quarters since. The position peaked at $6M in Q3 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Y-Intercept (HK) held 152,638 shares of Sabra Healthcare REIT worth $2.98M as of Q2 2026.
Sabra Healthcare REIT was a new Y-Intercept (HK) position in Q2 2026.
Sabra Healthcare REIT made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #480 holding.
Y-Intercept (HK) first reported a position in Sabra Healthcare REIT in Q3 2021 and has held it in 9 quarters since.
Y-Intercept (HK)'s Sabra Healthcare REIT position peaked at $6M in Q3 2025.
464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.